In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9
In vivo mutagenesis systems can often show restricted capabilities and deleterious off-site mutations. Here the authors fuse base deaminases to T7 RNA polymerase to mutate a target sequence and use dCas9 to define the boundaries of the diversified DNA.
Guardado en:
Autores principales: | Beatriz Álvarez, Mario Mencía, Víctor de Lorenzo, Luis Ángel Fernández |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5ba226df2154be6944359b80f7d8ffe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein
por: Yong Lei, et al.
Publicado: (2017) -
Genome-wide tracking of dCas9-methyltransferase footprints
por: Christina Galonska, et al.
Publicado: (2018) -
dCas9 regulator to neutralize competition in CRISPRi circuits
por: Hsin-Ho Huang, et al.
Publicado: (2021) -
Visualisation of dCas9 target search in vivo using an open-microscopy framework
por: Koen J. A. Martens, et al.
Publicado: (2019) -
Competitive dCas9 binding as a mechanism for transcriptional control
por: Daniel A Anderson, et al.
Publicado: (2021)